Adjuvant Intravesical Bacillus Calmette-Guérin Therapy and Survival Among Elderly Patients With Non–Muscle-Invasive Bladder Cancer

PURPOSE: National guidelines recommend adjuvant intravesical Bacillus Calmette-Guérin (BCG) therapy for higher-risk non–muscle-invasive bladder cancer (NMIBC). Although a survival benefit has not been demonstrated, randomized trials have shown reduced recurrence and delayed progression after its use...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Spencer, Benjamin A., McBride, Russell B., Hershman, Dawn L., Buono, Donna, Herr, Harry W., Benson, Mitchell C., Gupta-Mohile, Supriya, Neugut, Alfred I.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Clinical Oncology 2013
Témata:
Health Care Delivery
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3595445/
https://ncbi.nlm.nih.gov/pubmed/23814517
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JOP.2011.000480
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky